T. Rowe Price Health Sciences Fund Inc.: (MF: PRHSX)
(NASDAQ Mutual Funds) As of May 1, 2025 08:00 PM ET
$77.42 USD
-2.01 (-2.53%)
Fund Description
The fund was incepted in December 1995 and is managed by T.Rowe Price Associates. This health fund's main objective is long-term capital appreciation. The fund invests at least 80% of its net assets in common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. The fund may invest in companies of any size, the majority of fund assets are invested in large and mid capitalization companies. Dividends and capital gains, if any, are declared annually in December.
Load Information
Ticker | Max Load % |
Deferred Load % |
Red. Fee % |
12B-1 Fee % |
Mgmt Fee % |
Expense Ratio % |
|
---|---|---|---|---|---|---|---|
T. Rowe Price Health Sciences | PRHSX | NA | NA | 0.00 | 0.00 | 0.64 | 0.80 |
Return Data
Ticker | Nav | Inception Date | % yield | 1 year return | 2 year return | 3 year return | |
---|---|---|---|---|---|---|---|
T. Rowe Price Health Sciences | PRHSX | 78.59 | 12/29/1995 | 0.00 | -5.72 | 0.26 | 9.42 |
Investment Information
Ticker | Minimum Initial Investment ($) | Minimum Subsequent Investment ($) | Minimum Initial IRA ($) | Dividend Frequency | |
---|---|---|---|---|---|
T. Rowe Price Health Sciences | PRHSX | 2500 | 100 | 1000 | A |
Contact Information
Family | T. Rowe Price |
Address | 100 E Pratt Street Baltimore, MD 21202 |
Phone | 800 225-5132 |